Valiant Laboratories Limited
ListedMainboardIndustrial & Financial Services · NSE / BSE
Incorporated in 1980, Valiant Laboratories Limited is an Active Pharmaceutical Ingredient (API) manufacturing company in India primarily focused on producing Paracetamol. The company operates a manufacturing facility in Palghar, Maharashtra, spread across 2,000 sq. meters with a total installed annual capacity of 9,000 MT. Valiant Laboratories also has an in-house R&D facility equipped with an analytical laboratory and infrastructure to support development and improvement of existing products, strengthening its capabilities in the pharmaceutical ingredient space.
Price Band
₹133 – ₹140
Issue Size
₹152 Cr
Lot Size
105 shares
GMP
₹20
+14.3%
Est. Listing
₹160
at current GMP
Subscribed
29.75x
overall
Open
27 Sep 2023
Close
3 Oct 2023
Allotment
4 Oct 2023
Refund
5 Oct 2023
Demat Credit
6 Oct 2023
Listing
6 Oct 2023
Last updated 12 days ago
Live Grey Market Premium
Valiant Laboratories Limited GMP Today
Last updated: 19 Oct 2026
Current Premium
₹20+14.3%
Issue Price (Upper)
₹140
Band: ₹133 – ₹140
Estimated Listing Price
₹160
Upper price + GMP
Lot Size
105 shares
Min investment ₹14,700
Estimated Profit / Lot
₹2,100
105 × ₹20
Valiant Laboratories Limited GMP Historical Trend
GMP History
Grey Market Premium trend
+₹20
▲ 0 today
Updated 1 minute ago
Estimated Listing Price
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 31 Oct 2026 | +₹20 | 14.3% | ₹160 |
| 30 Oct 2026 | +₹20 | 14.3% | ₹160 |
| 29 Oct 2026 | +₹18 | 12.9% | ₹158 |
GMP is unofficial market data. Not a guarantee of listing performance.
About Valiant Laboratories Limited Public Issue & Market Profile
Valiant Laboratories Limited is bringing an initial public offering (IPO) in the Industrial & Financial Services sector with an aggregate issue size of ₹152 Crores. The shares are offered at a price band of ₹133 to ₹140 per equity share on NSE and BSE. Currently, market analysts recommend evaluating the company's financial valuation, price-to-earnings (P/E) multiple, and peer comparison prior to submitting bids.
Public Issue & Pricing Context:
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Basis of Allotment & Listing Timeline:
Following the close of bidding on 2023-10-03, the basis of allotment is scheduled to be finalized on 2023-10-04. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Link Intime India Private Limited) or the BSE allotment checking window.
Frequently Asked Questions
What is Valiant Laboratories Limited IPO GMP today?
The latest grey market premium for Valiant Laboratories Limited IPO is ₹20, which indicates an expected listing price of ₹160.
What does Kostak Rate and Sauda mean in IPO GMP?
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
Is Grey Market Premium officially recognized?
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.